Cerevel Therapeutics, Inc. (CERE) - Kompaniyaning xususiy kapitali
Cerevel Therapeutics (CERE) ixtisoslashtirilgan tibbiyot markazlarini nishonga olgan holda, Parkinson kasalligi va shizofreniyaga qarshi kurashish uchun innovatsion dori vositalarini ishlab chiqadi. Ushbu narxlar grafigi jarayon dinamikasini vizuallashtiradi, bunda ko'rsatkich 0.57 darajasida turibdi. Biznes dori vositalarini tashish paytida qat'iy harorat nazoratiga tayanadi. AbbVie bilan birlashish FDA tomonidan tartibga solinadigan ishlanmalar uchun mustahkam moliyalashtirishni va klinik sinov ishtirokchilari orasida yuqori sodiqlikni ta'minladi.
%20Kompaniyaning%20balans%20qiymati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_CERE_-_Cerevel-Therapeutics_-_Company-Book-Value "Cerevel Therapeutics Inc (CERE) Buxgalteriya kapitallashuvi: 04.07.2022 - 10.08.2024 davri uchun | 👁️GURU.Markets👁️")
Cerevel Therapeutics, Inc. (CERE) kompaniyasi koʻrsatkichlari kesimi va tahlili
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Cerevel Therapeutics|CERE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Cerevel Therapeutics Inc|CERE - Kompaniya qarzlari|Balans qiymatiga qarzlar Cerevel Therapeutics Inc|CERE - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Cerevel Therapeutics
Kompaniyaning jamlanma tahlili:CERE - Cerevel Corp
Ushbu ko'rsatkich barcha majburiyatlar ayirib tashlangan sof aktivlar qiymatini aks ettiradi, bu esa investorlarga biznesning real aktivlar poydevori qurlish sur'atini zudlik bilan kuzatish imkonini beradi. Cerevel Therapeutics (CERE) balansining baholanishi tahlili CNS bemorlari uchun neyroterapiyalarni ishlab chiqishga resurslar kapitalizatsiyasining samaradorligini tasdiqlaydi va dori vositalari sug'urta jamg'armasi bozoriga kirishidan oldin moliyaviy bazaning barqarorligini tasdiqlaydi.
Toʻgʻridan-toʻgʻri raqobatchilar
BIIB - Kompaniyaning buxgalteriya qiymati|Balans kapitallashuvi NBIX|RGC (regencellbioscience.com) - Kompaniyaning xususiy kapitali|Kompaniyaning balans qiymati Axsome Therapeutics, Inc. (AXSM)|Buxgalteriya kapitallashuvi ACADIA Pharma|Xenon Pharmaceuticals Inc - Balans kapitallashuvi|Kompaniyaning xususiy kapitali Viking Therapeutics Corp VKTX|Kompaniyaning sof aktivlari SUPN (Supernus Pharmaceuticals)|catalystpharma.com - Balans kapitallashuvi|Kompaniyaning balans qiymati Denali Therapeutics Inc. (DNLI)|HRMY: Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati BHVN|Amylyx Corp (AMLX) - Kompaniyaning xususiy kapitali|Balans kapitallashuvi TRVI|Kompaniyaning sof aktivlari praxismedicines.com|Anavex Life Sciences Corp. - Balans kapitallashuvi|Kompaniyaning xususiy kapitali CBLL (CeriBell Inc)|Kompaniyaning balans qiymati prothena.com|Kompaniyaning buxgalteriya qiymati Alector Inc. ALEC|ANNX (Annexon, Inc.) - Balans kapitallashuvi|Omeros Corporation (OMER) - Kompaniyaning xususiy kapitali|Neurogene (NGNE) - Kompaniyaning sof aktivlari|AC Immune S.A. (ACIU) - Kompaniyaning balans qiymati|Balans kapitallashuvi VYGR (Voyager Pharma)|Kompaniyaning xususiy kapitali NMRA|Kompaniyaning balans qiymati Scilex Holding Company (SCLX)|Kompaniyaning balans qiymati tevogen.com TVGN|Kompaniyaning sof aktivlari Alpha Cognition Inc.|CGTX - Kompaniyaning buxgalteriya qiymati|Kompaniyaning sof aktivlari Inhibikase IKT|SAVA - Jami sof aktivlar|Balans kapitallashuvi assertiotx.com ASRT|Coya Therapeutics (COYA) - Kompaniyaning buxgalteriya qiymati|Balans kapitallashuvi VTGN (VistaGen Therapeutics, Inc.)|Kompaniyaning xususiy kapitali OVID|Acumen Pharma (ABOS) - Kompaniyaning balans qiymati|Kompaniyaning buxgalteriya qiymati CervoMed Corporation (CRVO)|Balans kapitallashuvi ATHE (Alterity Therapeutics Limited)|Clene Inc - Balans kapitallashuvi|Kompaniyaning balans qiymati PepGen Corp|JUNS - Sof aktivlar qiymati|Balans kapitallashuvi RLMD|Kompaniyaning xususiy kapitali Annovis Bio Corporation|GRCE (Grace Therapeutics Inc) - Kompaniyaning sof aktivlari|Balans kapitallashuvi fireflyneuro.com (AIFF)|Kompaniyaning sof aktivlari Klotho Neurosciences Inc|Jami sof aktivlar neurosense-tx.com (NRSN)|Balans kapitallashuvi RVPH|Biznesning balans bahosi MetaVia Inc. MTVA|NRXS: Balans kapitallashuvi|HSDT: Kompaniyaning sof aktivlari|passagebio.com - Kompaniyaning balans qiymati|Neuphoria Therapeutics (NEUP) - Biznesning balans bahosi|Balans kapitallashuvi NERV|Kompaniyaning sof aktivlari Athira Pharma Corp|Addex Therapeutics - Balans kapitallashuvi|Kompaniyaning xususiy kapitali ALZN (alzamend.com)|Kompaniyaning balans qiymati Cyclerion Therapeutics, Inc.|Kompaniyaning buxgalteriya qiymati Protagenic Therapeutics Inc. PTIX|KTTA (Pasithea) - Balans kapitallashuvi|CRGT: Kompaniyaning xususiy kapitali|Kompaniyaning balans qiymati Avenue Therapeutics|brainstorm-cell.com (BCLI) - Buxgalteriya kapitallashuvi|Balans kapitallashuvi CARA (Cara Therapeutics)|Kompaniyaning xususiy kapitali Chromocell Therapeutics Corp (CHRO)|Kompaniyaning sof aktivlari ELYM|Balans kapitallashuvi ITCI (intracellulartherapies.com)|Kompaniyaning balans qiymati Longboard Pharmaceuticals|marinuspharma.com - Kompaniyaning buxgalteriya qiymati|NKGN (NKGen Biotech) - Kompaniyaning balans qiymati|NRBO - Kompaniyaning xususiy kapitali|SAGE (Sage Therapeutics, Inc) - Balans kapitallashuvi|Synaptogenix, Inc (SNPX) - Kompaniyaning sof aktivlari|Balans kapitallashuvi TRVN (Trevena, Inc.)|Kompaniyaning xususiy kapitali VIGL|Anew Medical, Inc. (WENA) - Kompaniyaning balans qiymati